160 related articles for article (PubMed ID: 20017928)
1. Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer.
Wildeman MA; Nyst HJ; Karakullukcu B; Tan BI
Head Neck Oncol; 2009 Dec; 1():40. PubMed ID: 20017928
[TBL] [Abstract][Full Text] [Related]
2. Salvage photodynamic therapy for recurrent nasopharyngeal carcinoma.
Succo G; Rosso S; Fadda GL; Fantini M; Crosetti E
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):63-70. PubMed ID: 24530994
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy as salvage therapy for patients with nasopharyngeal carcinoma experiencing local failures following definitive radiotherapy.
Stoker SD; Indrasari SR; Herdini C; Hariwiyanto B; Karakullukcu B; Dhamiyati W; Widayati K; Romdhoni AC; Fles R; Haryana SM; Wildeman MA; Tan IB
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):519-25. PubMed ID: 25917042
[TBL] [Abstract][Full Text] [Related]
4. The palliative role of PDT in recurrent advanced nasopharyngeal carcinoma: case series.
Abbas S; Jerjes W; Upile T; Vaz F; Hopper C
Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):142-7. PubMed ID: 22594984
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy for residual or recurrent cancer of the nasopharynx.
Kulapaditharom B; Boonkitticharoen V
J Med Assoc Thai; 1999 Nov; 82(11):1111-7. PubMed ID: 10659546
[TBL] [Abstract][Full Text] [Related]
6. Temoporfin mediated photodynamic therapy in patients with local persistent and recurrent nasopharyngeal carcinoma after curative radiotherapy: a feasibility study.
Nyst HJ; Wildeman MA; Indrasari SR; Karakullukcu B; van Veen RL; Adham M; Stewart FA; Levendag PC; Sterenborg HJ; Tan IB
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):274-81. PubMed ID: 22959807
[TBL] [Abstract][Full Text] [Related]
7. Remarkable response to photodynamic therapy in residual T4N0M0 nasopharyngeal carcinoma: a case report.
Indrasari SR; Timmermans AJ; Wildeman MA; Karakullukcu MB; Herdini C; Hariwiyanto B; Tan IB
Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):319-20. PubMed ID: 23200012
[TBL] [Abstract][Full Text] [Related]
8. In vivo fluence rate measurements during Foscan-mediated photodynamic therapy of persistent and recurrent nasopharyngeal carcinomas using a dedicated light applicator.
van Veen RL; Nyst H; Rai Indrasari S; Adham Yudharto M; Robinson DJ; Tan IB; Meewis C; Peters R; Spaniol S; Stewart FA; Levendag PC; Sterenborg HJ
J Biomed Opt; 2006; 11(4):041107. PubMed ID: 16965135
[TBL] [Abstract][Full Text] [Related]
9. Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications.
Chua DT; Sham JS; Kwong PW; Hung KN; Leung LH
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):177-83. PubMed ID: 12694836
[TBL] [Abstract][Full Text] [Related]
10. Meta-tetrahydroxyphenyl chlorine mediated photodynamic therapy inhibits the migration and invasion of a nasopharyngeal carcinoma KJ-1 cell line.
Wang CP; Lou PJ; Lo FY; Shieh MJ
J Formos Med Assoc; 2014 Mar; 113(3):173-8. PubMed ID: 24630035
[TBL] [Abstract][Full Text] [Related]
11. Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.
Dionisi F; Croci S; Giacomelli I; Cianchetti M; Caldara A; Bertolin M; Vanoni V; Pertile R; Widesott L; Farace P; Schwarz M; Amichetti M
Acta Oncol; 2019 Sep; 58(9):1238-1245. PubMed ID: 31155998
[No Abstract] [Full Text] [Related]
12. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results of photodynamic therapy for recurrent nasopharyngeal carcinoma.
Tong MC; van Hasselt CA; Woo JK
Eur Arch Otorhinolaryngol; 1996; 253(3):189-92. PubMed ID: 8652164
[TBL] [Abstract][Full Text] [Related]
14. Surface charge transition nano-theranostics based on ultra-small Fe
Bejjanki NK; Zhong Y; Liu J; Li Q; Xu H; Shen H; Xie M
Biochem Biophys Res Commun; 2021 Jun; 557():240-246. PubMed ID: 33894409
[TBL] [Abstract][Full Text] [Related]
15. Effect of photodynamic therapy on selected laboratory values of patients with nasopharyngeal carcinoma.
Lai JP; Tao ZD; Xiao JY; Zhao SP; Tian YQ
Ann Otol Rhinol Laryngol; 1997 Aug; 106(8):680-2. PubMed ID: 9270433
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
Qiu S; Lin S; Tham IW; Pan J; Lu J; Lu JJ
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):676-83. PubMed ID: 22024207
[TBL] [Abstract][Full Text] [Related]
17. Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer?
Licitra L; Bossi P; Locati LD; Bergamini C
J Clin Oncol; 2005 Oct; 23(30):7757-8; author reply 7758-9. PubMed ID: 16234549
[No Abstract] [Full Text] [Related]
18. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
[TBL] [Abstract][Full Text] [Related]
19. Combination of apoptin with photodynamic therapy induces nasopharyngeal carcinoma cell death in vitro and in vivo.
Fang X; Wu P; Li J; Qi L; Tang Y; Jiang W; Zhao S
Oncol Rep; 2012 Dec; 28(6):2077-82. PubMed ID: 22993053
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal carcinoma with orbital involvement.
Lee KY; Seah LL; Tow S; Cullen JF; Fong KS
Ophthalmic Plast Reconstr Surg; 2008; 24(3):185-9. PubMed ID: 18520832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
